Shunsuke Miura < Shunsuke Mori < Shunsuke Sasaoka

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by Shunsuke Mori

Number of relevant bibliographic references: 16.

Ident.	Authors (with country if any)	Title
000902 (2019)	Shunsuke Mori [Japon] ; Tamami Yoshitama [Japon] ; Yasuyo Abe [Japon] ; Toshihiko Hidaka [Japon] ; Naoyuki Hirakata [Japon] ; Kiyoshi Aoyagi [Japon] ; Yukitaka Ueki [Japon]	Retention of tocilizumab with and without methotrexate during maintenance therapy for rheumatoid arthritis: the ACTRA-RI cohort study.
001717 (2017)	Shunsuke Mori ; Tamami Yoshitama ; Naoyuki Hirakata ; Yukitaka Ueki	Prevalence of and factors associated with renal dysfunction in rheumatoid arthritis patients: a cross-sectional study in community hospitals
001864 (2017)	Shunsuke Mori [Japon] ; Tamami Yoshitama [Japon] ; Toshihiko Hidaka [Japon] ; Fumikazu Sakai [Japon] ; Mizue Hasegawa ; Yayoi Hashiba [Japon] ; Eiichi Suematsu [Japon] ; Hiroshi Tatsukawa [Japon] ; Akinari Mizokami [Japon] ; Shigeru Yoshizawa [Japon] ; Naoyuki Hirakata [Japon] ; Yukitaka Ueki [Japon]	Comparative risk of hospitalized infection between biological agents in rheumatoid arthritis patients: A multicenter retrospective cohort study in Japan.
001B66 (2016)	Shunsuke Mori [Japon] ; Yukinori Koga [Japon]	Glucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy.
002012 (2015)	Shunsuke Mori ; Shigetoshi Fujiyama	Hepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendations
002047 (2015)	Shunsuke Mori [Japon] ; Tamami Yoshitama [Japon] ; Toshihiko Hidaka [Japon] ; Naoyuki Hirakata [Japon] ; Yukitaka Ueki [Japon]	Effectiveness and safety of tocilizumab therapy for patients with rheumatoid arthritis and renal insufficiency: a real-life registry study in Japan (the ACTRA-RI study).
002145 (2015)	Shunsuke Mori [Japon] ; Mineharu Sugimoto [Japon]	Pneumocystis jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations
002847 (2013)	Shunsuke Mori [Japon] ; Yukitaka Ueki [Japon] ; Yukihiro Akeda [Japon] ; Naoyuki Hirakata [Japon] ; Motohiro Oribe [Japon] ; Yoshiki Shiohira [Japon] ; Toshihiko Hidaka [Japon] ; Kazunori Oishi [Japon]	Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy
003417 (2012)	Shunsuke Mori [Japon] ; Kaoru Terada ; Yukitaka Ueki	Tocilizumab-induced hyperbilirubinemia in Japanese patients with rheumatoid arthritis: its association with UDP glucuronosyltransferase 1A1 gene polymorphisms.
003469 (2012)	Shunsuke Mori [Japon] ; Hitoshi Tokuda ; Fumikazu Sakai ; Takeshi Johkoh ; Akio Mimori ; Norihiro Nishimoto ; Sadatomo Tasaka ; Kazuhiro Hatta ; Hidekazu Matsushima ; Shunji Kaise ; Atsushi Kaneko ; Shigeki Makino ; Seiji Minota ; Takashi Yamada ; Shinobu Akagawa ; Atsuyuki Kurashima	Radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents: a retrospective multicenter study in Japan.
003527 (2012)	Shunsuke Mori ; Shigetoshi Fujiyama	Comment on: Tocilizumab treatment in a patient suffering from rheumatoid arthritis and concomitant chronic hepatitis C infection.
003544 (2012)	Shunsuke Mori	Additional use of tacrolimus after switching to tocilizumab therapy in patients with primary lack of efficacy of infliximab therapy for rheumatoid arthritis.
003565 (2012)	Shunsuke Mori [Japon] ; Yukitaka Ueki [Japon] ; Naoyuki Hirakata [Japon] ; Motohiro Oribe [Japon] ; Toshihiko Hidaka [Japon] ; Kazunori Oishi [Japon]	Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis
003907 (2011)	Shunsuke Mori [Japon] ; Yukitaka Ueki	Primary lack of efficacy of infliximab therapy for rheumatoid arthritis: pharmacokinetic characterization and assessment of switching to tocilizumab.
003958 (2011)	Hideto Kameda [Japon] ; Hitoshi Tokuda ; Fumikazu Sakai ; Takeshi Johkoh ; Shunsuke Mori ; Yuji Yoshida ; Noboru Takayanagi ; Hirofumi Taki ; Yoshinori Hasegawa ; Kazuhiro Hatta ; Hisashi Yamanaka ; Makoto Dohi ; Shu Hashimoto ; Hidehiro Yamada ; Shinichi Kawai ; Tsutomu Takeuchi ; Kazuhiro Tateda ; Hajime Goto	Clinical and radiological features of acute-onset diffuse interstitial lung diseases in patients with rheumatoid arthritis receiving treatment with biological agents: importance of Pneumocystis pneumonia in Japan revealed by a multicenter study.
003D99 (2010)	Shunsuke Mori [Japon] ; Jun Hirose [Japon] ; Kensuke Yonemura [Japon]	Contribution of HLA-DRB1*04 alleles and anti-cyclic citrullinated antibodies to development of resistance to disease-modifying antirheumatic drugs in early rheumatoid arthritis

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "Shunsuke Mori" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "Shunsuke Mori" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    Shunsuke Mori
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021